Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers A > Headlines for AcelRx Pharmaceuticals, Inc. > News item |
AcelRx Pharmaceuticals plans to price public offering of common shares
Joint bookrunning managers Jefferies, Piper Jaffray assist with offer
By Devika Patel
Knoxville, Tenn., July 17 - AcelRx Pharmaceuticals, Inc. plans to price a public offering of common stock with a 30-day greenshoe option, according to a prospectus supplement filed Wednesday with the Securities and Exchange Commission.
Jefferies and Piper Jaffray are the joint bookrunning managers. Guggenheim Securities is the co-manager.
Proceeds will be used for regulatory approval of Zalviso in the United States and Europe, the commercial launch of Zalviso in the United States, working capital and general corporate purposes.
Based in Redwood City, Calif., AcelRx is a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of acute and breakthrough pain.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.